Search

everythinglearnresearchcommunity

for

Search:↓

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

The document provides 70 multiple choice questions to improve haematology skills.

AGEs may cause hair loss by increasing inflammation in hair follicles.

The model and estimator can predict drug exposure in kidney transplant patients well.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Lymphangiosarcoma was confirmed in cats with specific skin symptoms using a lymphatic marker.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

A man had two rare autoimmune diseases that might be connected.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Tislelizumab can cause cutaneous lupus erythematosus.

Autoimmune reactions may cause both alopecia areata and HAM.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Anti-CD19 therapy may help treat SLE and NMOSD.